Company Overview - Revvity, Inc. is headquartered in Waltham, MA, and provides scientific instruments, consumables, and services to various markets including pharmaceutical, biomedical, environmental testing, chemical, and general industrial sectors. The company was previously known as PerkinElmer until March 2023 [11]. Recent Developments - In March 2023, Revvity completed the sale of its Applied, Food and Enterprise Services (AES) businesses to New Mountain Capital for up to $2.45 billion. Following this divestiture, the company changed its name to Revvity effective April 26, 2023, and its ticker symbol changed from PKI to RVTY on May 16, 2023 [11]. Stock Performance - Revvity (RVTY) currently holds a 3 (Hold) rating on the Zacks Rank, with a VGM Score of B. The stock has a Momentum Style Score of A, and shares have increased by 4.9% over the past four weeks [12]. - Two analysts have revised their earnings estimates upwards for fiscal 2026, with the Zacks Consensus Estimate increasing by $0.02 to $5.33 per share. Revvity has an average earnings surprise of +4.1% [12]. Investment Consideration - With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, Revvity is recommended to be on investors' short list for potential investment opportunities [13].

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.It also includes access to the Zacks Style Scores. What a ...

Company Overview - C.H. Robinson Worldwide Inc. is a third-party logistics company based in Minnesota, providing freight transportation services and logistic solutions across various industries [11] - The company operates as an asset-light transportation provider, offering services ranging from specific shipment commitments to comprehensive and integrated logistics relationships [11] Investment Ratings - C.H. Robinson has a Zacks Rank of 2 (Buy) and a VGM Score of B, indicating a favorable investment outlook [11] Growth Potential - The company is positioned as a top pick for growth investors, with a Growth Style Score of A, forecasting a year-over-year earnings growth of 15.9% for the current fiscal year [12] - In the last 60 days, five analysts have revised their earnings estimates upwards for fiscal 2026, with the Zacks Consensus Estimate increasing by $0.05 to $5.90 per share [12] - C.H. Robinson has an average earnings surprise of +10.8%, further enhancing its attractiveness to investors [12]

Group 1: Company Performance - Aldeyra Therapeutics, Inc. (ALDX) has gained approximately 4.8% year-to-date, outperforming the Medical sector, which has seen an average gain of about 0.5% [4] - The Zacks Consensus Estimate for ALDX's full-year earnings has increased by 4.5% over the past quarter, indicating improved analyst sentiment and a stronger earnings outlook [4] - Aldeyra Therapeutics, Inc. is currently rated with a Zacks Rank of 2 (Buy), suggesting a positive outlook for the stock [3] Group 2: Industry Context - Aldeyra Therapeutics, Inc. is part of the Medical - Drugs industry, which consists of 141 companies and is currently ranked 159 in the Zacks Industry Rank [6] - Stocks in the Medical - Drugs industry have gained about 1.6% year-to-date, indicating that ALDX is performing better than its industry peers [6] - In contrast, ANI Pharmaceuticals, another stock in the Medical sector, has a year-to-date return of 1.3% and is part of the Medical - Biomedical and Genetics industry, which has declined by 4.4% this year [5][7]

Group 1 - Accor SA - Sponsored ADR (ACCYY) is part of the Consumer Discretionary sector, which includes 257 individual stocks and holds a Zacks Sector Rank of 12 [2] - The Zacks Rank system indicates that Accor SA has a current Zacks Rank of 2 (Buy), suggesting a favorable outlook for the stock [3] - The Zacks Consensus Estimate for ACCYY's full-year earnings has increased by 1.7% over the past quarter, indicating improved analyst sentiment and a more positive earnings outlook [4] Group 2 - Year-to-date, Accor SA has returned approximately 0.1%, outperforming the average loss of 3.6% in the Consumer Discretionary group [4] - Accor SA belongs to the Hotels and Motels industry, which consists of 15 individual stocks and currently ranks 96 in the Zacks Industry Rank; this industry has gained about 2.8% so far this year, indicating that ACCYY is slightly underperforming its industry [6] - Investors should continue to monitor Accor SA and Cumulus Media, as both stocks have shown solid performance in the Consumer Discretionary sector [7]

Company Overview - Lockheed Martin Corporation is one of the largest defense contractors globally, focusing on defense, space, intelligence, homeland security, and information technology, including cybersecurity [12] - In 2025, 72% of Lockheed Martin's net sales were derived from the U.S. Government, with 63% from the Department of War and 28% from international customers [12] Investment Ratings - Lockheed Martin currently holds a 3 (Hold) rating on the Zacks Rank, with a VGM Score of B [13] - The company has a Value Style Score of B, supported by attractive valuation metrics such as a forward P/E ratio of 21.42, making it appealing to value investors [13] Earnings Estimates - In the last 60 days, three analysts have revised their earnings estimates upwards for fiscal 2026, with the Zacks Consensus Estimate increasing by $0.04 to $29.69 per share [13] - Lockheed Martin has an average earnings surprise of +14%, indicating a positive trend in earnings performance [13] Investment Consideration - With a solid Zacks Rank and strong Value and VGM Style Scores, Lockheed Martin is recommended for investors' consideration [14]

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though?Let's take a look at what these Wall Street heavyweights have to say about Apple (AAPL) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.Apple currently has an average broke ...

Core Viewpoint - Deluxe (DLX) has shown strong stock performance, with shares increasing by 28% over the past month and reaching a new 52-week high of $28.24 [1] Performance Summary - Deluxe has outperformed the Zacks Business Services sector, gaining 24.7% year-to-date compared to the sector's -3.3% and the Zacks Business - Office Products industry's 18.8% return [1] Earnings Performance - The company has a strong record of positive earnings surprises, beating the Zacks Consensus Estimate in the last four quarters, with the latest EPS reported at $0.96 against an estimate of $0.83 [2] Earnings Forecast - For the current fiscal year, Deluxe is expected to post earnings of $3.88 per share on revenues of $2.13 billion, reflecting a 5.72% change in EPS and a -0.2% change in revenues. For the next fiscal year, earnings are projected at $4.42 per share on revenues of $2.16 billion, indicating a year-over-year change of 13.92% and 1.49%, respectively [3] Valuation Metrics - Deluxe trades at 7.2X current fiscal year EPS estimates, below the peer industry average of 9.5X. On a trailing cash flow basis, it trades at 4.5X compared to the peer group's average of 6.8X. The stock has a PEG ratio of 0.6, positioning it favorably for value investors [7] Style Scores - Deluxe has a Value Score of A, a Growth Score of B, and a Momentum Score of D, resulting in a combined VGM Score of A, indicating strong value potential [6] Zacks Rank - The stock holds a Zacks Rank of 1 (Strong Buy) due to a solid earnings estimate revision trend, making it a suitable choice for investors looking for high-ranking stocks [8]

Core Viewpoint - Shore Bancshares (SHBI) has shown strong stock performance, with a 9.7% increase over the past month and a new 52-week high of $19.64, outperforming the Zacks Finance sector and the Zacks Banks - Northeast industry [1] Financial Performance - Shore Bancshares has consistently beaten earnings estimates, reporting an EPS of $0.53 against a consensus estimate of $0.48 in its last earnings report [2] - For the current fiscal year, the company is expected to post earnings of $1.97 per share on revenues of $244.37 million, reflecting no change in EPS and an 8.58% increase in revenues [3] - For the next fiscal year, earnings are projected to rise to $2.22 per share on revenues of $262.45 million, indicating a year-over-year growth of 12.69% in EPS and 7.4% in revenues [3] Valuation Metrics - Shore Bancshares has a Value Score of B, a Growth Score of C, and a Momentum Score of A, resulting in a VGM Score of A [6] - The stock trades at 9.9X current fiscal year EPS estimates, slightly above the peer industry average of 9.8X, and at 11.7X trailing cash flow compared to the peer group's average of 12.3X [7] Zacks Rank - Shore Bancshares holds a Zacks Rank of 2 (Buy), supported by a solid earnings estimate revision trend, indicating potential for further stock price appreciation [8] Industry Comparison - The Banks - Northeast industry is performing well, ranking in the top 22% of all industries, providing favorable conditions for both Shore Bancshares and its peer, Washington Trust Bancorp, Inc. (WASH) [11]

Company Performance - Viav Solutions (VIAV) has seen a significant stock increase of 41.3% over the past month, reaching a new 52-week high of $26.08 [1] - Year-to-date, the stock has gained 43.6%, outperforming the Zacks Computer and Technology sector's 2.3% gain and the Zacks Communication - Components industry's 20.7% return [1] Earnings and Revenue Expectations - Viav Solutions has a strong track record of positive earnings surprises, having met or exceeded earnings consensus estimates in the last four quarters [2] - For the current fiscal year, the company is expected to report earnings of $0.80 per share on revenues of $1.46 billion, reflecting a 70.21% increase in EPS and a 35.09% increase in revenues [3] - For the next fiscal year, earnings are projected to be $0.95 per share on revenues of $1.66 billion, indicating a year-over-year change of 19.69% in EPS and 13.52% in revenues [3] Valuation Metrics - Viav Solutions currently trades at 32.1 times the current fiscal year EPS estimates, aligning with the peer industry average [7] - On a trailing cash flow basis, the stock trades at 40.1 times, significantly higher than the peer group's average of 14.2 times, suggesting it may not be in the top echelon from a value perspective [7] Zacks Rank and Style Scores - The company holds a Zacks Rank of 2 (Buy), supported by a solid earnings estimate revision trend [8] - Viav Solutions has a Value Score of D, while its Growth and Momentum Scores are both A, resulting in a combined VGM Score of B [6] Industry Comparison - Ooma, Inc. (OOMA), a peer in the industry, also has a Zacks Rank of 2 (Buy) and shows strong performance with a Value Score of A and a Growth Score of A [9] - OOMA is expected to post earnings of $1.20 per share on revenues of $272.46 million for the current fiscal year, having beaten consensus estimates by 22.73% last quarter [10] - The Communication - Components industry is positioned in the top 22% of all industries, indicating favorable conditions for both VIAV and OOMA [11]